ea0056p1123 | Thyroid cancer | ECE2018
Williams Alejandra
, Santon Almudena
, Pian Hector
, Cristobal Eva
, Iglesias Pedro
, Diez Juan J
Background: The BRAFV600E mutation is the most common mutation in papillary thyroid carcinoma (PTC). Its presence has been associated with extrathyroid invasion, lymph node metastasis, and tumor recurrence. Recently, assessment of the BRAFV600E mutation status in patients with PTC has been used as a method to predict tumor aggressiveness.Objective: Our aim has been to analyze the prevalence of BRAFV60...